GlassScriptPhysician profile
Darlene Espinosa
NPI 1619105541
$1,464.14
in general payments reported to CMS, 2019-2025
34 companies · $78.30 in 2025
The $78.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $52.28 · 2021: $232 · 2022: $244 · 2023: $177 · 2025: $78.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $209.67 | 2019-2023 | Prolia, Evenity |
| Abbvie INC. | $160.22 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.78 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $107.97 | 2019-2021 | |
| Novo Nordisk INC | $83.39 | 2019-2021 | |
| Abbott Laboratories | $78.30 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $52.80 | 2019 | |
| Bard Peripheral Vascular, INC. | $50.94 | 2023 | Venclose Maven Catheter |
| Glaxosmithkline, LLC. | $49.93 | 2022-2023 | Shingrix |
| Merck Sharp & Dohme LLC | $45.43 | 2019-2021 | |
| Mannkind Corporation | $44.29 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.74 | 2019-2021 | |
| Antares Pharma, INC. | $34.10 | 2022 | |
| Esperion Therapeutics, INC. | $32.82 | 2021 | |
| Astellas Pharma US INC | $31.88 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $28.85 | 2019 | |
| Hologic Sales and Service, LLC | $23.62 | 2023 | Aptima, Thinprep 2000 Processor |
| Baxter Healthcare | $23.51 | 2022 | |
| Biogen, INC. | $21.51 | 2021 | |
| Amarin Pharma, INC. | $20.61 | 2019 | |
| Endo Pharmaceuticals INC. | $20.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.99 | 2022 | |
| Grifols USA, LLC | $19.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.87 | 2019 | |
| Shionogi INC | $16.66 | 2019 | |
| Tactile Systems Technology INC | $16.27 | 2023 | Entre Plus, Flexitouch Plus |
| E.R. Squibb & Sons, L.L.C. | $15.83 | 2019 | |
| Lilly USA, LLC | $14.93 | 2019 | |
| Acadia Pharmaceuticals INC | $13.87 | 2020 | |
| Allergan, INC. | $13.69 | 2019 | |
| Therapeuticsmd, INC. | $13.58 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darlene Espinosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.